Retrospective Study
Copyright ©The Author(s) 2025.
World J Nephrol. Mar 25, 2025; 14(1): 98837
Published online Mar 25, 2025. doi: 10.5527/wjn.v14.i1.98837
Table 1 Patients characteristics, mean ± SD
Variable
G1
G2
G3a
G3b
G4
G5
P value
Age of males, years81.7 ± 5.880.6 ± 3.981.7 ± 5.880.6 ± 3.982.6 ± 5.082.5 ± 4.70.106
Age of females, years79.9 ± 3.580.1 ± 3.979.9 ± 3.580.1 ± 3.981.8 ± 4.881.8 ± 3.9
Serum urea nitrogen (mg/dL)19 ± 821 ± 728 ± 1339 ± 2063 ± 2887 ± 250.01
Creatinine (mg/dL)0.64 ± 0.10.87 ± 0.11.18 ± 0.171.56 ± 0.22.42 ± 0.554.88 ± 2.090.01
GFR (mL/kg/1.73 m2)109.1 ± 1872.4 ± 8.152.2 ± 4.237.8 ± 4.623.1 ± 4.411.1 ± 3.20.01
Hemoglobin (g/dL)11 ± 311 ± 311 ± 311 ± 211 ± 211 ± 20.01
Hematocrit (g/dL)33 ± 935 ± 834 ± 933 ± 734 ± 834 ± 70.01
No comorbidity, n (%)111 ± 24, 24 (16.3)73.7 ± 9, 64 (43.5)52.5 ± 4.6, 29 (19.7)38.8 ± 4.1, 21 (14.3)23.4 ± 3.3, 7 (4.8)12.5 ± 2.1, 2 (1.4)0.010
MDS, n (%)136 ± 36, 4 (16)69 ± 6.7, 12 (48)48.1 ± 3.4, 3 (12)35.4 ± 4.1, 4 (16)20.7 ± 6, 12 (8)00.396
Diabetes, n (%)105 ± 11.5, 21 (12.7)72.6 ± 7.7, 43 (25.9)51.8 ± 3.6, 27 (16.3)37.5 ± 4.6, 42 (25.3)23.2 ± 4.4, 18 (10.8%)11 ± 3.4, 15 (9%)0.020
Alzheimer’s, n (%)112 ± 12, 11 (25)74.6 ± 7.8, 9 (20.5)50.5 ± 3.3, 6 (13.6)35.7 ± 5, 6 (13.6)24.9 ± 3.8, 9 (20.5%)8.1 ± 4, 3 (6.8%)0.078
CAD, n (%)103 ± 0.6, 2 (9.5)70.5 ± 10, 552.2 ± 8 (31)52.2 ± 5.5, 2 (9.5)35.3 ± 3, 3 (14.3)24.5 ± 6.7, 3 (14.3)11.5 ± 1.3, 3 (14.3)0.690
CVO, n (%)95.8 ± 6.4, 2 (20)69.6, 1 (10)036.6 ± 8.9, 2 (20)16.9, 1 (10)12 ± 2.8, 4 (40)0.046
Arterial hypertension, n (%)107 ± 15, 27 (16)71 ± 7.4, 57 (33.9)52.6 ± 4.5, 24 (14.3)39.1 ± 4.5, 24 (14.3)22.2 ± 4.5, 19 (11.3)11.3 ± 3.5, 17 (10.1)0.341
COPD, n (%)111.6, 1 (12.5)74.9 ± 17, 2 (25)54 ± 2, 43 (37.5)021.9 ± 5.2, 2 (25)00.279
Cancer, n (%)081.4, 1 (9,1)56.9 ± 2.1, 2 (18.2)37.2 ± 5.3, 6 (54.5)28.5, 1 (9.1)10.2, 1 (9.1)0.034